SCS Capital Management’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.34M Buy
458,515
+1,732
+0.4% +$5.17K 0.01% 250
2026
Q2
$1.43M Buy
456,783
+1,741
+0.4% +$5.44K 0.01% 246
2026
Q1
$1.33M Buy
455,042
+14,133
+3% +$40.4K 0.01% 242
2025
Q4
$1.09M Buy
440,909
+2,276
+0.5% +$5.42K 0.01% 273
2025
Q3
$978K Buy
+438,633
New +$1M 0.01% 291

Other funds holding ABEV

SCS Capital Management's ABEV Position: Q3 2026 in Review

SCS Capital Management increased its Ambev (ABEV) stake by 0.38% in Q3 2026, buying an estimated $5.17K and bringing the position to 458,515 shares worth $1.34M. The position accounts for 0.01% of the portfolio, ranked #250.

SCS Capital Management first reported a position in ABEV in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.43M in Q2 2026. 329 funds tracked by Wall St. Rank hold ABEV as of Q3 2026.

  • SCS Capital Management held 458,515 shares of Ambev worth $1.34M as of Q3 2026.
  • SCS Capital Management bought 1,732 Ambev shares in Q3 2026, an estimated $5.17K.
  • Ambev made up 0.01% of SCS Capital Management's portfolio in Q3 2026, its #250 holding.
  • SCS Capital Management first reported a position in Ambev in Q3 2025 and has held it in 5 quarters since.
  • SCS Capital Management's Ambev position peaked at $1.43M in Q2 2026.
  • 329 funds tracked by Wall St. Rank held Ambev as of Q3 2026.

Based on SCS Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.